𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

✍ Scribed by Jun-Feng Han; Ting-Ting Zhao; Hong-Li Liu; Zhi-Hua Lin; Hui-Ming Wang; Zhi-Hua Ruan; Li-Yun Zou; Yu-Zhang Wu

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
316 KB
Volume
55
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of a new HLA-A*0201-restr
Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1
✍ Britta Maecker; Michael S. von Bergwelt-Baildon; David H. Sherr; Lee M. Nadler; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 100 KB

## Abstract Cytochrome P450 1B1 (CYP1B1) was recently shown to be a candidate tumor antigen broadly expressed in solid and hematologic malignancies. Nevertheless, use of such self‐antigens as targets for immune intervention can be limited because of loss of high‐avidity T cells during negative sele

Identification of HLA-B27–restricted cyt
Identification of HLA-B27–restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen
✍ Eduardo Huarte; Pablo Sarobe; Juan José Lasarte; Gottfried Brem; Elisabeth H. We 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB

## Abstract Characterization of epitopes recognized by cytotoxic T lymphocytes (CTLs) in the sequence of tumor antigens is an important step in the development of tumor therapies. Because carcinoembryonic antigen (CEA) is a protein expressed in a high number of epithelial tumors, it is an interesti

Identification of an HLA-A*0201 cytotoxi
Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2
✍ Judith M. Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S. Mo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB

## Abstract Tie‐2 stabilises pericyte–endothelial interactions during angiogenesis and is highly expressed on endothelium during several diseases, including arthritis, age‐related macular degeneration and cancer. A vaccine that targets endothelium overexpressing Tie‐2 may result in vessel damage an